The Recombinant Nitrosomonas europaea Outer-membrane lipoprotein carrier protein (LolA) is a recombinant form of the LolA protein, which plays a crucial role in the transport of lipoproteins across bacterial membranes. LolA proteins are generally involved in the translocation of lipoproteins from the inner membrane to the outer membrane in Gram-negative bacteria. In the case of Nitrosomonas europaea, this recombinant protein is produced in yeast or other expression systems to facilitate research and applications in biotechnology and microbiology.
LolA functions as a molecular chaperone, protecting the hydrophobic acyl chains of lipoproteins from the aqueous environment of the periplasm. It forms a complex with lipoproteins and transports them across the periplasm to the outer membrane, where they are transferred to another protein, LolB, for final incorporation into the outer membrane . This process is essential for the proper localization and functioning of outer membrane lipoproteins.
Recombinant Nitrosomonas europaea LolA is produced using various expression systems, including yeast and E. coli . The choice of expression system can affect the yield, purity, and properties of the recombinant protein. For instance, yeast expression systems are often used for producing proteins with complex structures or post-translational modifications.
Research on recombinant LolA proteins focuses on understanding their role in bacterial membrane biogenesis and their potential applications in biotechnology. For example, studying the LolA-LolB system can provide insights into developing new antimicrobial strategies targeting bacterial membrane assembly .
KEGG: neu:NE1052
STRING: 228410.NE1052
LolA functions as a periplasmic chaperone protein that accepts triacylated lipoproteins from the inner membrane LolCDE transporter complex and carries them across the periplasm to the outer membrane receptor LolB. This trafficking system is essential for proper localization of outer membrane lipoproteins, which are vital structural components of the outer membrane in gram-negative bacteria like N. europaea . The Lol system underpins the formation and maintenance of the outer membrane that constitutes a vital protective barrier against antibiotics and other harmful molecules .
Nitrosomonas europaea possesses a single circular chromosome of 2,812,094 bp with 2,460 protein-encoding genes averaging 1,011 bp in length . While the specific genomic context of lolA in N. europaea is not directly addressed in the provided materials, in gram-negative bacteria, lolA is typically part of the essential lol operon. N. europaea has genes distributed evenly around the genome, with approximately 47% transcribed from one strand and 53% from the complementary strand . The relatively compact genome with limited genes for catabolism of organic compounds but plentiful genes for inorganic ion transporters reflects N. europaea's specialized niche as an obligate chemolithoautotroph .
Crystal structure analysis has revealed that LolA accommodates the three acyl chains of lipoproteins in a precise conformation within its hydrophobic cavity. The protein forms extensive interactions with the acyl chains but not with any amino acid residues of the cargo lipoprotein . This structural arrangement explains LolA's ability to transport structurally diverse lipoproteins, as its binding specificity is directed toward the lipid moiety rather than the protein portion. The structure shows how LolA, initially primed to receive lipoprotein by interaction with LolC, further opens to accommodate the three ligand acyl chains .
While specific expression conditions for recombinant N. europaea LolA are not detailed in the provided materials, general approaches for gram-negative bacterial lipoprotein expression systems would apply with modifications. For functional studies of LolA, expression systems should consider:
Expression vector selection: pET-based systems with T7 promoters are commonly used for periplasmic proteins
Host strain selection: E. coli strains lacking certain proteases (like BL21(DE3)) are preferred
Growth conditions: Lower temperatures (16-25°C) after induction often improve proper folding
Induction parameters: Lower IPTG concentrations (0.1-0.5 mM) can enhance soluble protein yield
N. europaea has specialized metabolic requirements as an obligate chemolithoautotroph that derives all energy from ammonia oxidation , which should be considered when designing expression systems for its proteins.
For purification of recombinant LolA, a multi-step approach would typically include:
Affinity chromatography: Histidine-tagged LolA can be purified using Ni-NTA columns
Size exclusion chromatography: To separate monomeric LolA from aggregates or other proteins
Ion exchange chromatography: To remove contaminating proteins based on charge differences
Critical quality control measures should include:
Assessment of structural integrity through circular dichroism
Verification of lipoprotein binding capacity through in vitro binding assays
Confirmation of proper folding via tryptophan fluorescence assays
The purification should aim to maintain the native conformational state of LolA that allows it to undergo the open/closed transitions essential for lipoprotein transport .
Based on structural insights, researchers can assess LolA's lipoprotein binding capability through:
In vitro binding assays: Using purified triacylated lipoproteins or synthetic lipoprotein mimics with fluorescent labels to measure binding affinity through techniques like fluorescence anisotropy.
Structural analysis: Crystallography of LolA in complex with cargo lipoproteins reveals the precise accommodation of acyl chains in the hydrophobic cavity .
Mutagenesis studies: Targeting residues in the hydrophobic cavity that interact with acyl chains to validate their importance in lipoprotein binding.
Pull-down assays: Using immobilized LolA to capture interacting lipoproteins from cellular extracts, followed by mass spectrometry identification.
The crystal structure shows that LolA forms extensive interactions with the acyl chains but not with any residue of the cargo protein, explaining its ability to transport structurally diverse lipoproteins .
Researchers can investigate LolA-LolCDE interactions through:
Co-immunoprecipitation: Using antibodies against LolA to pull down the LolCDE complex from membrane preparations.
Surface plasmon resonance: Measuring binding kinetics between immobilized LolA and purified LolCDE or just the periplasmic domain of LolC.
Structural analysis: Comparison of existing structures shows substantial overlap of the lipoprotein and LolC binding sites within the LolA cavity, demonstrating that insertion of lipoprotein acyl chains physically disengages the chaperone from the transporter by perturbing interaction with LolC .
Cross-linking studies: Chemical cross-linking followed by mass spectrometry can identify interaction sites between LolA and LolC.
The structural data reveals how LolA is primed to receive lipoprotein by interaction with LolC before further opening to accommodate the lipoprotein acyl chains .
While specific information about lolA regulation in N. europaea is not provided in the search results, several insights from N. europaea transcriptomic studies can inform research approaches:
Oxygen limitation effects: Studies on N. europaea have shown differential gene expression under oxygen-limited growth conditions . Researchers could investigate whether lolA expression is similarly affected, as outer membrane integrity may be particularly important under stress conditions.
Nitrogen cycling genes: N. europaea participates in the biogeochemical N cycle through nitrification . The relationship between nitrogen metabolism genes and membrane transport systems could be examined to determine if lolA expression correlates with ammonia oxidation rates.
Stress response: Given that the Lol system is essential for outer membrane integrity, examining lolA expression under various stressors (pH shifts, presence of toxins, temperature variations) could reveal regulatory patterns.
Comparison with related genes: Examining lolA expression in relation to other membrane biogenesis genes could provide insights into coordinated regulation of envelope formation.
For accurate quantification of lolA expression in N. europaea, researchers should consider:
RT-qPCR: Designing primers specific to N. europaea lolA for transcript quantification, with appropriate reference genes selected based on stability under the experimental conditions.
RNA-Seq: For genome-wide transcriptome analysis that places lolA expression in context with other genes. This approach has been successfully used to study transcriptomic responses in N. europaea under different growth conditions .
Protein quantification: Western blotting with antibodies specific to LolA or targeted proteomics approaches like selected reaction monitoring (SRM) to quantify protein levels.
Reporter gene fusions: Construction of lolA promoter fusions to reporter genes (GFP, luciferase) for real-time monitoring of expression in living cells.
When analyzing expression data, researchers should account for N. europaea's unique physiological characteristics as an obligate chemolithoautotroph with specialized energy metabolism .
Structure-function analysis of LolA reveals:
Hydrophobic cavity residues: Amino acids lining the cavity that interact with the three acyl chains of lipoproteins are critical for binding. Mutations in these residues would likely disrupt lipoprotein binding .
LolC interaction interface: Residues at the interface between LolA and LolC are essential for the initial priming of LolA to receive lipoproteins. Structural analysis shows substantial overlap between lipoprotein and LolC binding sites within the LolA cavity .
Conformational change mediators: Residues that facilitate the opening/closing transitions of LolA are crucial. A liganded LolA variant incapable of lipoprotein release shows aberrant association, demonstrating the importance of the LolCDE-coordinated, sequential opening of LolA for proper trafficking .
Species-specific variations: Comparing LolA sequences across different bacteria, including N. europaea, could identify conserved vs. variable regions that may reflect adaptation to specific lipoproteins or environmental conditions.
While direct information on lolA mutations in N. europaea is not provided, researchers could investigate:
Conditional knockdown/knockout strategies: Since the Lol system is essential, conditional approaches would be needed to study partial loss of function.
Point mutations: Engineering specific mutations based on structural insights to test hypotheses about LolA function without completely inactivating the protein.
Physiological assessments: Measuring ammonia oxidation rates, nitrite production, and growth rates in mutant strains to correlate LolA function with N. europaea's primary metabolism.
Membrane integrity analysis: As proper lipoprotein localization is critical for outer membrane integrity, testing membrane permeability and antibiotic sensitivity in lolA mutants.
Stress response capacity: Evaluating how lolA mutations affect the ability of N. europaea to handle environmental stressors, particularly those affecting the cell envelope.
N. europaea's specialized metabolism as an obligate chemolithoautotroph that derives all energy from ammonia oxidation means that membrane integrity defects resulting from lolA mutations could have significant impacts on its bioenergetics and nitrogen transformation capabilities.
A comparative analysis of LolA across different bacterial species would examine:
Sequence conservation: Analyzing primary structure conservation between N. europaea LolA and homologs from other gram-negative bacteria, including other ammonia-oxidizing bacteria and model organisms like E. coli.
Structural variations: Comparing the hydrophobic cavity architecture that accommodates lipoprotein acyl chains across species to identify adaptations for specific lipoprotein repertoires.
LolC interaction domains: Examining variations in the interface between LolA and LolC across species, as this interaction is critical for the initial priming of LolA to receive lipoproteins .
Evolutionary adaptations: Correlating LolA variations with the ecological niches of different bacteria, potentially reflecting adaptations to specific environmental conditions.
N. europaea's unique physiology as an obligate chemolithoautotroph may have influenced the evolution of its membrane transport systems, including LolA, to support its specialized metabolism.
Researchers investigating the connection between LolA and nitrogen metabolism could explore:
Co-regulation patterns: Examining whether genes involved in ammonia oxidation (amo, hao) and the lol system show coordinated expression patterns under different environmental conditions.
Envelope stress response: Determining how disruptions in lipoprotein transport affect ammonia monooxygenase and hydroxylamine oxidoreductase localization and activity.
Metabolic integration: Investigating how the energy demands of the Lol system are integrated with the bioenergetics of ammonia oxidation in N. europaea.
Environmental adaptations: Comparing LolA across different ammonia-oxidizing bacteria to identify adaptations that may correlate with their ecological niches and roles in the nitrogen cycle.
N. europaea participates in the biogeochemical N cycle through nitrification, converting ammonia to nitrite , and proper functioning of membrane systems is likely critical for these processes.
The structural basis of LolA-lipoprotein interactions offers several approaches for antimicrobial development:
Targeting the hydrophobic cavity: Designing small molecules that occupy the hydrophobic cavity of LolA and prevent lipoprotein binding. The crystal structure shows that LolA accommodates the three lipoprotein acyl chains in a precise conformation .
Disrupting LolA-LolC interactions: Developing compounds that interfere with the interaction between LolA and LolC, preventing the initial priming of LolA to receive lipoproteins. Structural analysis shows substantial overlap between lipoprotein and LolC binding sites .
Trapping conformational states: Creating molecules that lock LolA in either open or closed conformations, preventing the transitions necessary for lipoprotein transport.
Species-specific targeting: Identifying unique features of LolA in target pathogens compared to commensal bacteria to develop selective antimicrobials.
The Lol system is particularly promising as an antimicrobial target because it is essential for outer membrane formation in gram-negative bacteria, and the outer membrane is a critical protective barrier against antibiotics .
Investigating real-time dynamics of LolA-mediated trafficking could employ:
Fluorescence microscopy techniques:
FRET pairs attached to LolA and lipoproteins to monitor interactions
Single-molecule tracking of fluorescently labeled LolA to observe trafficking dynamics
Super-resolution microscopy to visualize LolA localization patterns
Biosensors:
Conformational sensors that report on the open/closed states of LolA
FRET-based sensors that detect lipoprotein binding to LolA
In vitro reconstitution systems:
Artificial membrane systems with purified LolCDE, LolA, and LolB to reconstitute the complete trafficking pathway
Microfluidic approaches to visualize lipoprotein transfer between membrane compartments
Kinetic studies:
Stopped-flow spectroscopy to measure rates of conformational changes in LolA upon lipoprotein binding
Real-time measurements of lipoprotein transfer from LolCDE to LolA and from LolA to LolB
These approaches could provide insights into how the sequential opening of LolA, coordinated by LolCDE, enables productive lipoprotein trafficking .